Summary
Danaher Corporation (DHR) announced a significant debt financing event through its subsidiary, DH Europe Finance II S.à r.l. (Danaher International II). On September 3, 2019, Danaher International II entered into an underwriting agreement to issue and sell a substantial aggregate principal amount of €6.25 billion in senior notes across various maturities ranging from 2026 to 2049. These notes carry coupon rates from a low of 0.200% up to 1.800% and are fully guaranteed by Danaher Corporation. This offering is a strategic move to fund a portion of the cash consideration and associated costs for Danaher's acquisition of the Biopharma Business of GE Life Sciences. This debt issuance is a key step in facilitating Danaher's significant growth strategy through the GE Biopharma acquisition. The substantial amount raised indicates the scale of the transaction and Danaher's commitment to this strategic integration. Investors should note the diversification of maturities and the relatively low coupon rates, reflecting favorable market conditions and Danaher's credit standing. The net proceeds are earmarked for a major acquisition, underscoring the company's active management and pursuit of inorganic growth opportunities. Pending the closing of the acquisition, the funds will be held in short-term investments.
Key Highlights
- 1Danaher International II is issuing €6.25 billion in senior notes with maturities from 2026 to 2049.
- 2The notes carry interest rates ranging from 0.200% to 1.800%.
- 3Danaher Corporation is providing a full and unconditional guarantee for the issued notes.
- 4The primary purpose of this debt issuance is to finance a portion of the acquisition of GE Life Sciences' Biopharma Business.
- 5The offering is expected to generate approximately €6.197 billion in net proceeds after fees and discounts.
- 6The closing of the note offering is anticipated to occur on September 18, 2019, subject to standard conditions.
- 7Pending the acquisition, proceeds will be invested in short-term bank deposits or investment-grade securities.